Dynavax Technologies | Attività





Attività Cambiamento Data
AbbVie USD 133.9B 3.28B 2025-09
Adma Biologics USD 568.69M 10.31M 2025-09
Agenus USD 233.89M 48.67M 2025-09
Amgen USD 90.59B 445M 2025-12
AstraZeneca USD 114.07B 382M 2025-12
Biogen USD 29.44B 232M 2025-12
BioMarin Pharmaceutical USD 7.61B 158.53M 2025-09
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Dynavax Technologies USD 946.51M 28.06M 2025-09
Gilead Sciences USD 59.02B 490M 2025-12
Glaxosmithkline GBP 82.45B 23.19B 2025-09
Merck USD 129.55B 12.02B 2025-09
Minerva Neurosciences USD 28.09M 2.33M 2025-09
Nektar Therapeutics USD 301.35M 93.81M 2025-09
Neurocrine Biosciences USD 4.63B 365.8M 2025-12
Novartis USD 107.29B 2.89B 2025-09
Pfizer USD 208.73B 2.64B 2025-09
Regeneron Pharmaceuticals USD 40.56B 389.3M 2025-12
Roche Holding CHF 100.7B 5.94B 2025-12
Sarepta Therapeutics USD 3.49B 186.38M 2025-09
TG Therapeutics USD 1.03B 322.41M 2025-09
Vertex Pharmaceuticals USD 24.86B 825.6M 2025-09


Dynavax Technologies Attività - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.